Literature DB >> 6874502

Mycoplasma felis as a cause of pleuritis in horses.

T H Ogilvie, S Rosendal, T E Blackwell, C M Rostkowski, R J Julian, L Ruhnke.   

Abstract

Mycoplasma felis was the only organism recovered from the thoracic cavity of a horse with pleuritis. Large numbers of mildly degenerative neutrophils were in the pleural fluid. The horse developed a serologic response to M felis and recovered during hospitalization. Experimentally, a pony was inoculated in the thoracic cavity with a pure culture of the M felis isolate suspended in the pony's serum. A control pony was inoculated with serum only. Within 48 hours, the principal pony developed fever, increased respiratory rate, pleural effusion, and signs of pain. A highly cellular exudate with nondegenerative neutrophils and large numbers of M felis was recovered from the thoracic cavity. The control pony remained normal. The principal pony developed an antibody response to M felis. The control pony did not. Fourteen days after inoculation, both ponies were euthanatized. Necropsy revealed pleural inflammation in the principal pony. Pleural lesions were not found in the control pony.

Entities:  

Mesh:

Year:  1983        PMID: 6874502

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  3 in total

1.  Identification of Mycoplasma felis and Mycoplasma gateae by an immunobinding assay.

Authors:  M B Brown; P Gionet; D F Senior
Journal:  J Clin Microbiol       Date:  1990-08       Impact factor: 5.948

2.  Evaluation of a guarded bronchoscopic method for microbial sampling of the lower airways in foals.

Authors:  A M Hoffman; L Viel; C A Muckle; D B Tesarowski
Journal:  Can J Vet Res       Date:  1991-10       Impact factor: 1.310

3.  High prevalence of Mycoplasma equirhinis in Thoroughbred horses with respiratory symptoms in autumn 2018.

Authors:  Eri Uchida-Fujii; Yuta Kinoshita; Hidekazu Niwa; Tatsuya Maeda; Toshio Nukada; Takanori Ueno
Journal:  J Vet Med Sci       Date:  2021-11-04       Impact factor: 1.267

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.